LTRN Lantern Pharma Inc
Company Analysis
Latest News
🔴 Lantern Pharma is trading 5.7% down today on profit-taking after recent AI spin-out rally
Lantern Pharma is trading at $2.64 (5.7% down) in after-hours trading on apparent profit-taking following a multi-day rally. • The stock is pulling back from...
🟢 Lantern Pharma is trading 7.3% up today on EMA trial clearance and AI spin-out launch
Lantern Pharma is trading 7.3% up today at $2.80 as investors react to the late-July EMA clearance for its LP-184 Phase 1b/2 trial and the launch of its AI...
🟢 Lantern Pharma is trading 5.3% up today on EMA clearance for bladder cancer trial
Lantern Pharma is trading 5.3% up today at $2.77 as investor momentum builds following a major regulatory milestone in Europe. • The European Medicines Agency...
🟢 Lantern Pharma is trading 10.3% up today after EMA clearance for LP-184 bladder cancer trial
Lantern Pharma is trading at $2.90 (10.3% up) following momentum from the European Medicines Agency (EMA) clearing a Phase 1b/2 trial for its lead candidate,...
Lantern Pharma secures EMA clearance for LP-184, targeting recurrent bladder cancer
Lantern Pharma Inc. received clearance from the European Medicines Agency (EMA) to launch a Phase 1b/2 clinical trial for its lead candidate, LP-184. The study...
🟢 Lantern Pharma is trading 9.6% up today amid a broader risk-on rally in tech stocks
Lantern Pharma is trading at $2.70 (+9.56%) today as part of a broader risk-on move in U.S. equities. • The Nasdaq Composite is up 2.45% as technology stocks...
🔴 Lantern Pharma falls 5.1% — Biotech Stocks Decline on Broad Market Weakness
With Biotech (XBI) down 2.2%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 Lantern Pharma is trading 5.2% down today after hitting a new 52-week low of $2.77
Lantern Pharma is trading 5.2% down today at $2.94 after hitting a new 52-week low of $2.77, extending a steep decline from its prior high of $8.27. • Recent...
🟢 Lantern Pharma is trading 5.9% up today in a technical bounce after a sharp regular-session drop
Lantern Pharma is trading at $3.25 (+5.9%) in after-hours trading, appearing to stage a technical bounce following a volatile regular session. • The stock is...
🔴 Lantern Pharma is trading 10.1% down
Lantern Pharma is trading at $3.11, down 10.1% from a comparison close of $3.46 during regular trading. This is a price-action follow-up, so a separate...
🔴 Lantern Pharma is trading 5.8% down today on broader biotech sell-off and profit-taking
Lantern Pharma is trading 5.8% down at $3.26 amid a broader biotech sell-off and profit-taking that has weighed on high-beta names across the sector. • The...
🟢 Lantern Pharma is trading 6% up today as it extends rebound from recent sharp selloff
Lantern Pharma is trading 6% up today at $3.55, extending its recovery following significant volatility earlier in the week. • The move follows an 8.06% gain...
🟢 Lantern Pharma is trading 5.6% up today in a technical rebound after sharp declines
Lantern Pharma is trading 5.6% up at $3.27 in a technical rebound following two sessions of sharp declines. • The stock is recovering from yesterday’s 13.17%...
🔴 LTRN makes sharp 11.5% drop
LTRN is trading at $3.16, down 11.5% versus the comparison close of $3.57 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 LTRN Dips 5.3% Despite Launch of New AI Platform ZetaOmics™
Lantern Pharma (LTRN) stock is trading 5.3% down today at $3.38, continuing recent weakness. The decline comes despite the company's announcement on July 8,...
🔴 LTRN makes sharp 10.2% drop
LTRN is trading at $3.53, down 10.2% versus the comparison close of $3.93 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 LTRN is trading 6.1% down today in a pullback from its recent oncology pipeline-driven rally
LTRN is trading at $3.69 (6.1% down) as the stock pulls back from a recent pre-market jump to $4.17. • The recent upward momentum was driven by renewed...
🟢 LTRN is trading 6.1% up today on renewed oncology pipeline interest and FDA trial progress
LTRN is trading at $4.17 (6.1% up) in pre-market, bouncing after recent volatility as interest returns to its oncology pipeline. • Sentiment is supported by...
🔴 LTRN is trading 5.3% down today as it pulls back from a multi-week uptrend
LTRN is trading 5.3% down at $3.95 today, giving back a portion of its recent multi-week gains in a move likely driven by technical factors. • The decline...
🟢 Lantern Pharma Inc is trading 6.22% up
LTRN is trading at $4.10, up 6.22%.